Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery

Jennifer Johnston discusses how a better understanding of ubiquitin-proteasome system elements can potentially aid neurodegenerative disease therapeutics.

The Scientist Creative Services Team in collaboration with Bio-Techne
Sep 15, 2021

LIVE Webinar

Wednesday, September 29, 2021
2:30 - 3:30 PM Eastern Time

Register Now

Approximately 40% of human diseases may be attributable to defects in the cellular proteostasis machinery, including the ubiquitin-proteasome system.  Accumulation of misfolded, damaged, or aggregated proteins can lead to prolonged stress, accumulation of reactive oxygen species, and cell death.  In this webinar, brought to you by Bio-Techne, Jennifer Johnston will discuss how her research of ubiquitin-proteasome system elements, including Parkin E3 ligase, is used to diagnose and treat diseases caused by defects in proteostasis pathways.

Topics to be covered

  • The basics of the ubiquitin-proteasome system
  • The biology and druggability of ubiquitin E3 ligases
  • Modifications of ubiquitin proteins and their therapeutic and diagnostic applications

Register Now

Meet the Speaker:

Jennifer Johnston, PhD
Cofounder and CEO

Sponsored By


October 2021

Number Sense

Researchers debate how animals perceive quantities


Sponsored Product Updates

Controlling Western Blot Quality and Compliance
Learn how to follow pharmaceutical industry regulations when performing western blot experiments from start to finish.
Charting a Path to Clean Laboratory Air
Are you working with pathogens or volatiles? Use this flowchart to determine what safety cabinet or fume hood is necessary for any experimental situation.